Instrument Inactif

Communiqués Primary Health Care Limited Australian S.E.

Actions

AU000000PRY5

Installations et services en soins de santé

Communiqués

21/08/24	Practices and pathology providers – prohibited practices and the ‘Red Book': know your obligations	AQ
15/12/23	ACCC opposes Australian Clinical Labs' proposed acquisition of Healius	AQ
13/11/23	Medical practices and pathology providers – Prohibited practices and the 'Red Book': know your obligations	AQ
20/03/23	No Enthusiasm To Combine ACL & Healius	AQ
01/02/23	Agilex - Stephen McIntyre Joins Agilex Biolabs as CEO	AQ
22/09/22	CN Diagnostics Partners with Grupo Fleury to Bring Pioneering Blood Tests to Brazil for Advancing Brain Health	AQ
30/08/22	C2N Diagnostics and Healius Ltd Announce Partnership to Bring PrecivityAD™ and Related Brain Health Biomarkers to Patients in Australia	BU
05/07/22	Healius : Application for quotation of securities - HLS	PU
16/06/22	Healius : Update - Notification of buy-back - HLS	PU
14/06/22	Healius : Update - Notification of buy-back - HLS	PU
09/06/22	Healius : Update - Notification of buy-back - HLS	PU
07/06/22	Healius : Update - Notification of buy-back - HLS	PU
02/06/22	Healius : Update - Notification of buy-back - HLS	PU
30/05/22	Healius : Update - Notification of buy-back - HLS	PU
20/05/22	Healius : Strategy Day Presentation	PU
02/05/22	Healius : Update - Notification of buy-back - HLS	PU
29/04/22	Healius : Update - Notification of buy-back - HLS	PU
27/04/22	Healius : Update - Notification of buy-back - HLS	PU
19/04/22	Healius : Update - Notification of buy-back - HLS	PU
14/04/22	Healius : Update - Notification of buy-back - HLS	PU
11/04/22	Healius : Update - Notification of buy-back - HLS	PU
07/04/22	Healius : Update - Notification of buy-back - HLS	PU
04/04/22	Healius : Update - Notification of buy-back - HLS	PU
31/03/22	Healius : Notification regarding unquoted securities - HLS	PU
24/02/22	Healius : Application for quotation of securities - HLS	PU